Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.
2.

Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):109-14.

3.
4.

Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.

Tóth PP, Potter D, Ming EE.

J Clin Lipidol. 2012 Jul-Aug;6(4):325-30. doi: 10.1016/j.jacl.2012.05.002. Epub 2012 May 22.

PMID:
22836069
5.

Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey.

Zhang B, Menzin J, Friedman M, Korn JR, Burge RT.

Curr Med Res Opin. 2008 Sep;24(9):2711-7. doi: 10.1185/03007990802363198 . Epub 2008 Aug 12.

PMID:
18701005
6.

National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.

Cullen MW, Stein JH, Gangnon R, McBride PE, Keevil JG.

Am Heart J. 2008 Aug;156(2):284-91. doi: 10.1016/j.ahj.2008.03.004. Epub 2008 Jun 4.

PMID:
18657658
8.

Prevalence of cholesterol screening and high blood cholesterol among adults--United States, 2005, 2007, and 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Sep 7;61:697-702.

9.

Relative importance of borderline and elevated levels of coronary heart disease risk factors.

Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundström J, Kannel WB, Levy D, D'Agostino RB.

Ann Intern Med. 2005 Mar 15;142(6):393-402. Erratum in: Ann Intern Med. 2005 Apr 19;142(8):681.

PMID:
15767617
10.
12.
13.

Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease. Application of the Second Adult Treatment Panel guidelines.

Allen JK, Young DR, Blumenthal RS, Moy TF, Yanek LR, Wilder L, Becker LC, Becker DM.

Arch Intern Med. 1996 Aug 12-26;156(15):1654-60.

PMID:
8694663
15.

High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults.

Bilhorn KR, Luo Y, Lee BT, Wong ND.

Am J Cardiol. 2012 Nov 15;110(10):1464-7. doi: 10.1016/j.amjcard.2012.06.056. Epub 2012 Aug 2.

PMID:
22858184
16.

Prevalence of multiple cardiac risk factors in US adults with diabetes.

McCollum M, Ellis SL, Morrato EH, Sullivan PW.

Curr Med Res Opin. 2006 Jun;22(6):1031-4.

PMID:
16846537
17.

Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).

Guttormsen BN, Stein JH, McBride PE, Cullen MW, Gangnon R, Keevil JG.

Am J Cardiol. 2007 Oct 1;100(7):1130-3. Epub 2007 Jul 18.

PMID:
17884376
18.

Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.

Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.

Am J Cardiol. 2007 Nov 15;100(10):1499-501. Epub 2007 Sep 27.

PMID:
17996508
19.

Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.

Hyre AD, Muntner P, Menke A, Raggi P, He J.

Ann Epidemiol. 2007 Jul;17(7):548-55. Epub 2007 Mar 28.

PMID:
17395483
20.

Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.

McNicoll S, Latour Y, Rondeau C, Bouthillier D, Davignon J, Genest J Jr.

Can J Cardiol. 1995 Feb;11(2):109-16.

PMID:
7866933

Supplemental Content

Support Center